Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jan 1;97(1):14–21. doi: 10.1172/JCI118382

Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.

C Slemenda 1, C Longcope 1, M Peacock 1, S Hui 1, C C Johnston 1
PMCID: PMC507057  PMID: 8550826

Abstract

Although bone loss around the time of menopause is driven by estrogen deficiency, the roles of estrogens and androgens in the preservation of skeletal mass at other stages of life are less well understood. To address this issue we studied 231 women between the ages of 32 and 77 with multiple measurements of sex steroids and bone mass over a period of 2-8 yr. In all women bone mass was negatively associated with concentrations of sex-hormone binding globulin, and positively associated with weight. Bone loss occurred from all skeletal sites in peri- and postmenopausal women, but premenopausal women lost bone only from the hip (-0.3%/yr) and had positive rates of change in the radius and spine. Bone loss was significantly associated with lower androgen concentrations in premenopausal women, and with lower estrogens and androgens in peri- and postmenopausal women. Sex steroids are important for the maintenance of skeletal integrity before menopause, and for as long as 20-25 yr afterwards.

Full Text

The Full Text of this article is available as a PDF (161.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armamento-Villareal R., Villareal D. T., Avioli L. V., Civitelli R. Estrogen status and heredity are major determinants of premenopausal bone mass. J Clin Invest. 1992 Dec;90(6):2464–2471. doi: 10.1172/JCI116138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buchanan J. R., Hospodar P., Myers C., Leuenberger P., Demers L. M. Effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab. 1988 Nov;67(5):937–943. doi: 10.1210/jcem-67-5-937. [DOI] [PubMed] [Google Scholar]
  3. Cauley J. A., Gutai J. P., Sandler R. B., LaPorte R. E., Kuller L. H., Sashin D. The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women. Am J Epidemiol. 1986 Nov;124(5):752–761. doi: 10.1093/oxfordjournals.aje.a114451. [DOI] [PubMed] [Google Scholar]
  4. Crosby L. O., Kaplan F. S., Pertschuk M. J., Mullen J. L. The effect of anorexia nervosa on bone morphometry in young women. Clin Orthop Relat Res. 1985 Dec;(201):271–277. [PubMed] [Google Scholar]
  5. Cummings S. R., Black D. M., Nevitt M. C., Browner W., Cauley J., Ensrud K., Genant H. K., Palermo L., Scott J., Vogt T. M. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993 Jan 9;341(8837):72–75. doi: 10.1016/0140-6736(93)92555-8. [DOI] [PubMed] [Google Scholar]
  6. Cummings S. R., Nevitt M. C., Browner W. S., Stone K., Fox K. M., Ensrud K. E., Cauley J., Black D., Vogt T. M. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995 Mar 23;332(12):767–773. doi: 10.1056/NEJM199503233321202. [DOI] [PubMed] [Google Scholar]
  7. Dixon J. E., Rodin A., Murby B., Chapman M. G., Fogelman I. Bone mass in hirsute women with androgen excess. Clin Endocrinol (Oxf) 1989 Mar;30(3):271–277. doi: 10.1111/j.1365-2265.1989.tb02235.x. [DOI] [PubMed] [Google Scholar]
  8. Drinkwater B. L., Bruemner B., Chesnut C. H., 3rd Menstrual history as a determinant of current bone density in young athletes. JAMA. 1990 Jan 26;263(4):545–548. [PubMed] [Google Scholar]
  9. Fisher E. C., Nelson M. E., Frontera W. R., Turksoy R. N., Evans W. J. Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women. J Clin Endocrinol Metab. 1986 Jun;62(6):1232–1236. doi: 10.1210/jcem-62-6-1232. [DOI] [PubMed] [Google Scholar]
  10. Lindsay R., Hart D. M., Forrest C., Baird C. Prevention of spinal osteoporosis in oophorectomised women. Lancet. 1980 Nov 29;2(8205):1151–1154. doi: 10.1016/s0140-6736(80)92592-1. [DOI] [PubMed] [Google Scholar]
  11. Looker A. C., Johnston C. C., Jr, Wahner H. W., Dunn W. L., Calvo M. S., Harris T. B., Heyse S. P., Lindsay R. L. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res. 1995 May;10(5):796–802. doi: 10.1002/jbmr.5650100517. [DOI] [PubMed] [Google Scholar]
  12. Robinson T. L., Snow-Harter C., Taaffe D. R., Gillis D., Shaw J., Marcus R. Gymnasts exhibit higher bone mass than runners despite similar prevalence of amenorrhea and oligomenorrhea. J Bone Miner Res. 1995 Jan;10(1):26–35. doi: 10.1002/jbmr.5650100107. [DOI] [PubMed] [Google Scholar]
  13. Slemenda C. W., Johnston C. C. High intensity activities in young women: site specific bone mass effects among female figure skaters. Bone Miner. 1993 Feb;20(2):125–132. doi: 10.1016/s0169-6009(08)80021-9. [DOI] [PubMed] [Google Scholar]
  14. Slemenda C., Hui S. L., Longcope C., Johnston C. C. Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest. 1987 Nov;80(5):1261–1269. doi: 10.1172/JCI113201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sowers M. R., Clark M. K., Hollis B., Wallace R. B., Jannausch M. Radial bone mineral density in pre- and perimenopausal women: a prospective study of rates and risk factors for loss. J Bone Miner Res. 1992 Jun;7(6):647–657. doi: 10.1002/jbmr.5650070609. [DOI] [PubMed] [Google Scholar]
  16. Steinberg K. K., Freni-Titulaer L. W., DePuey E. G., Miller D. T., Sgoutas D. S., Coralli C. H., Phillips D. L., Rogers T. N., Clark R. V. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 1989 Sep;69(3):533–539. doi: 10.1210/jcem-69-3-533. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES